Ziprasidone (Geodon, Zeldox)

Indications


Pharmacology

  • xxxx

Metabolism

  • xxxx

Administration

  • xxx

Dose Adjustment

  • Hepatic
  • Renal

Adverse Effects

Cardiovascular Adverse Effects

QT Prolongation without Definite Association with Torsade (see Torsade, [[Torsade]])

  • xxxx

Dermatologic Adverse Effects

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) (Drug-Induced Hypersensitivity Syndrome, DIHS) (see Drug Rash with Eosinophilia and Systemic Symptoms)

  • Epidemiology: FDA warning issued 2015 (related to 6 reported cases of DRESS syndrome)
  • Clinical: onset occurred between day 11-30 of drug initiation
  • Prognosis: no reported deaths

Other Adverse Effects

  • xxx

References

  • xxx